table of content
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2022-2027)
1.4.2 East Asia Market States and Outlook (2022-2027)
1.4.3 Europe Market States and Outlook (2022-2027)
1.4.4 South Asia Market States and Outlook (2022-2027)
1.4.5 Southeast Asia Market States and Outlook (2022-2027)
1.4.6 Middle East Market States and Outlook (2022-2027)
1.4.7 Africa Market States and Outlook (2022-2027)
1.4.8 Oceania Market States and Outlook (2022-2027)
1.4.9 South America Market States and Outlook (2022-2027)
1.5 Global Therapeutic Radiopharmaceuticals Market Size Analysis from 2022 to 2027
1.5.1 Global Therapeutic Radiopharmaceuticals Market Size Analysis from 2022 to 2027 by Consumption Volume
1.5.2 Global Therapeutic Radiopharmaceuticals Market Size Analysis from 2022 to 2027 by Value
1.5.3 Global Therapeutic Radiopharmaceuticals Price Trends Analysis from 2022 to 2027
1.6 COVID-19 Outbreak: Therapeutic Radiopharmaceuticals Industry Impact
Chapter 2 Global Therapeutic Radiopharmaceuticals Competition by Types, Applications, and Top Regions and Countries
2.1 Global Therapeutic Radiopharmaceuticals (Volume and Value) by Type
2.1.1 Global Therapeutic Radiopharmaceuticals Consumption and Market Share by Type (2016-2021)
2.1.2 Global Therapeutic Radiopharmaceuticals Revenue and Market Share by Type (2016-2021)
2.2 Global Therapeutic Radiopharmaceuticals (Volume and Value) by Application
2.2.1 Global Therapeutic Radiopharmaceuticals Consumption and Market Share by Application (2016-2021)
2.2.2 Global Therapeutic Radiopharmaceuticals Revenue and Market Share by Application (2016-2021)
2.3 Global Therapeutic Radiopharmaceuticals (Volume and Value) by Regions
2.3.1 Global Therapeutic Radiopharmaceuticals Consumption and Market Share by Regions (2016-2021)
2.3.2 Global Therapeutic Radiopharmaceuticals Revenue and Market Share by Regions (2016-2021)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2016-2021 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2016-2021 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Therapeutic Radiopharmaceuticals Sales, Consumption, Export, Import by Regions (2016-2021)
4.1 Global Therapeutic Radiopharmaceuticals Consumption by Regions (2016-2021)
4.2 North America Therapeutic Radiopharmaceuticals Sales, Consumption, Export, Import (2016-2021)
4.3 East Asia Therapeutic Radiopharmaceuticals Sales, Consumption, Export, Import (2016-2021)
4.4 Europe Therapeutic Radiopharmaceuticals Sales, Consumption, Export, Import (2016-2021)
4.5 South Asia Therapeutic Radiopharmaceuticals Sales, Consumption, Export, Import (2016-2021)
4.6 Southeast Asia Therapeutic Radiopharmaceuticals Sales, Consumption, Export, Import (2016-2021)
4.7 Middle East Therapeutic Radiopharmaceuticals Sales, Consumption, Export, Import (2016-2021)
4.8 Africa Therapeutic Radiopharmaceuticals Sales, Consumption, Export, Import (2016-2021)
4.9 Oceania Therapeutic Radiopharmaceuticals Sales, Consumption, Export, Import (2016-2021)
4.10 South America Therapeutic Radiopharmaceuticals Sales, Consumption, Export, Import (2016-2021)
Chapter 5 North America Therapeutic Radiopharmaceuticals Market Analysis
5.1 North America Therapeutic Radiopharmaceuticals Consumption and Value Analysis
5.1.1 North America Therapeutic Radiopharmaceuticals Market Under COVID-19
5.2 North America Therapeutic Radiopharmaceuticals Consumption Volume by Types
5.3 North America Therapeutic Radiopharmaceuticals Consumption Structure by Application
5.4 North America Therapeutic Radiopharmaceuticals Consumption by Top Countries
5.4.1 United States Therapeutic Radiopharmaceuticals Consumption Volume from 2016 to 2021
5.4.2 Canada Therapeutic Radiopharmaceuticals Consumption Volume from 2016 to 2021
5.4.3 Mexico Therapeutic Radiopharmaceuticals Consumption Volume from 2016 to 2021
Chapter 6 East Asia Therapeutic Radiopharmaceuticals Market Analysis
6.1 East Asia Therapeutic Radiopharmaceuticals Consumption and Value Analysis
6.1.1 East Asia Therapeutic Radiopharmaceuticals Market Under COVID-19
6.2 East Asia Therapeutic Radiopharmaceuticals Consumption Volume by Types
6.3 East Asia Therapeutic Radiopharmaceuticals Consumption Structure by Application
6.4 East Asia Therapeutic Radiopharmaceuticals Consumption by Top Countries
6.4.1 China Therapeutic Radiopharmaceuticals Consumption Volume from 2016 to 2021
6.4.2 Japan Therapeutic Radiopharmaceuticals Consumption Volume from 2016 to 2021
6.4.3 South Korea Therapeutic Radiopharmaceuticals Consumption Volume from 2016 to 2021
Chapter 7 Europe Therapeutic Radiopharmaceuticals Market Analysis
7.1 Europe Therapeutic Radiopharmaceuticals Consumption and Value Analysis
7.1.1 Europe Therapeutic Radiopharmaceuticals Market Under COVID-19
7.2 Europe Therapeutic Radiopharmaceuticals Consumption Volume by Types
7.3 Europe Therapeutic Radiopharmaceuticals Consumption Structure by Application
7.4 Europe Therapeutic Radiopharmaceuticals Consumption by Top Countries
7.4.1 Germany Therapeutic Radiopharmaceuticals Consumption Volume from 2016 to 2021
7.4.2 UK Therapeutic Radiopharmaceuticals Consumption Volume from 2016 to 2021
7.4.3 France Therapeutic Radiopharmaceuticals Consumption Volume from 2016 to 2021
7.4.4 Italy Therapeutic Radiopharmaceuticals Consumption Volume from 2016 to 2021
7.4.5 Russia Therapeutic Radiopharmaceuticals Consumption Volume from 2016 to 2021
7.4.6 Spain Therapeutic Radiopharmaceuticals Consumption Volume from 2016 to 2021
7.4.7 Netherlands Therapeutic Radiopharmaceuticals Consumption Volume from 2016 to 2021
7.4.8 Switzerland Therapeutic Radiopharmaceuticals Consumption Volume from 2016 to 2021
7.4.9 Poland Therapeutic Radiopharmaceuticals Consumption Volume from 2016 to 2021
Chapter 8 South Asia Therapeutic Radiopharmaceuticals Market Analysis
8.1 South Asia Therapeutic Radiopharmaceuticals Consumption and Value Analysis
8.1.1 South Asia Therapeutic Radiopharmaceuticals Market Under COVID-19
8.2 South Asia Therapeutic Radiopharmaceuticals Consumption Volume by Types
8.3 South Asia Therapeutic Radiopharmaceuticals Consumption Structure by Application
8.4 South Asia Therapeutic Radiopharmaceuticals Consumption by Top Countries
8.4.1 India Therapeutic Radiopharmaceuticals Consumption Volume from 2016 to 2021
8.4.2 Pakistan Therapeutic Radiopharmaceuticals Consumption Volume from 2016 to 2021
8.4.3 Bangladesh Therapeutic Radiopharmaceuticals Consumption Volume from 2016 to 2021
Chapter 9 Southeast Asia Therapeutic Radiopharmaceuticals Market Analysis
9.1 Southeast Asia Therapeutic Radiopharmaceuticals Consumption and Value Analysis
9.1.1 Southeast Asia Therapeutic Radiopharmaceuticals Market Under COVID-19
9.2 Southeast Asia Therapeutic Radiopharmaceuticals Consumption Volume by Types
9.3 Southeast Asia Therapeutic Radiopharmaceuticals Consumption Structure by Application
9.4 Southeast Asia Therapeutic Radiopharmaceuticals Consumption by Top Countries
9.4.1 Indonesia Therapeutic Radiopharmaceuticals Consumption Volume from 2016 to 2021
9.4.2 Thailand Therapeutic Radiopharmaceuticals Consumption Volume from 2016 to 2021
9.4.3 Singapore Therapeutic Radiopharmaceuticals Consumption Volume from 2016 to 2021
9.4.4 Malaysia Therapeutic Radiopharmaceuticals Consumption Volume from 2016 to 2021
9.4.5 Philippines Therapeutic Radiopharmaceuticals Consumption Volume from 2016 to 2021
9.4.6 Vietnam Therapeutic Radiopharmaceuticals Consumption Volume from 2016 to 2021
9.4.7 Myanmar Therapeutic Radiopharmaceuticals Consumption Volume from 2016 to 2021
Chapter 10 Middle East Therapeutic Radiopharmaceuticals Market Analysis
10.1 Middle East Therapeutic Radiopharmaceuticals Consumption and Value Analysis
10.1.1 Middle East Therapeutic Radiopharmaceuticals Market Under COVID-19
10.2 Middle East Therapeutic Radiopharmaceuticals Consumption Volume by Types
10.3 Middle East Therapeutic Radiopharmaceuticals Consumption Structure by Application
10.4 Middle East Therapeutic Radiopharmaceuticals Consumption by Top Countries
10.4.1 Turkey Therapeutic Radiopharmaceuticals Consumption Volume from 2016 to 2021
10.4.2 Saudi Arabia Therapeutic Radiopharmaceuticals Consumption Volume from 2016 to 2021
10.4.3 Iran Therapeutic Radiopharmaceuticals Consumption Volume from 2016 to 2021
10.4.4 United Arab Emirates Therapeutic Radiopharmaceuticals Consumption Volume from 2016 to 2021
10.4.5 Israel Therapeutic Radiopharmaceuticals Consumption Volume from 2016 to 2021
10.4.6 Iraq Therapeutic Radiopharmaceuticals Consumption Volume from 2016 to 2021
10.4.7 Qatar Therapeutic Radiopharmaceuticals Consumption Volume from 2016 to 2021
10.4.8 Kuwait Therapeutic Radiopharmaceuticals Consumption Volume from 2016 to 2021
10.4.9 Oman Therapeutic Radiopharmaceuticals Consumption Volume from 2016 to 2021
Chapter 11 Africa Therapeutic Radiopharmaceuticals Market Analysis
11.1 Africa Therapeutic Radiopharmaceuticals Consumption and Value Analysis
11.1.1 Africa Therapeutic Radiopharmaceuticals Market Under COVID-19
11.2 Africa Therapeutic Radiopharmaceuticals Consumption Volume by Types
11.3 Africa Therapeutic Radiopharmaceuticals Consumption Structure by Application
11.4 Africa Therapeutic Radiopharmaceuticals Consumption by Top Countries
11.4.1 Nigeria Therapeutic Radiopharmaceuticals Consumption Volume from 2016 to 2021
11.4.2 South Africa Therapeutic Radiopharmaceuticals Consumption Volume from 2016 to 2021
11.4.3 Egypt Therapeutic Radiopharmaceuticals Consumption Volume from 2016 to 2021
11.4.4 Algeria Therapeutic Radiopharmaceuticals Consumption Volume from 2016 to 2021
11.4.5 Morocco Therapeutic Radiopharmaceuticals Consumption Volume from 2016 to 2021
Chapter 12 Oceania Therapeutic Radiopharmaceuticals Market Analysis
12.1 Oceania Therapeutic Radiopharmaceuticals Consumption and Value Analysis
12.2 Oceania Therapeutic Radiopharmaceuticals Consumption Volume by Types
12.3 Oceania Therapeutic Radiopharmaceuticals Consumption Structure by Application
12.4 Oceania Therapeutic Radiopharmaceuticals Consumption by Top Countries
12.4.1 Australia Therapeutic Radiopharmaceuticals Consumption Volume from 2016 to 2021
12.4.2 New Zealand Therapeutic Radiopharmaceuticals Consumption Volume from 2016 to 2021
Chapter 13 South America Therapeutic Radiopharmaceuticals Market Analysis
13.1 South America Therapeutic Radiopharmaceuticals Consumption and Value Analysis
13.1.1 South America Therapeutic Radiopharmaceuticals Market Under COVID-19
13.2 South America Therapeutic Radiopharmaceuticals Consumption Volume by Types
13.3 South America Therapeutic Radiopharmaceuticals Consumption Structure by Application
13.4 South America Therapeutic Radiopharmaceuticals Consumption Volume by Major Countries
13.4.1 Brazil Therapeutic Radiopharmaceuticals Consumption Volume from 2016 to 2021
13.4.2 Argentina Therapeutic Radiopharmaceuticals Consumption Volume from 2016 to 2021
13.4.3 Columbia Therapeutic Radiopharmaceuticals Consumption Volume from 2016 to 2021
13.4.4 Chile Therapeutic Radiopharmaceuticals Consumption Volume from 2016 to 2021
13.4.5 Venezuela Therapeutic Radiopharmaceuticals Consumption Volume from 2016 to 2021
13.4.6 Peru Therapeutic Radiopharmaceuticals Consumption Volume from 2016 to 2021
13.4.7 Puerto Rico Therapeutic Radiopharmaceuticals Consumption Volume from 2016 to 2021
13.4.8 Ecuador Therapeutic Radiopharmaceuticals Consumption Volume from 2016 to 2021
Chapter 14 Company Profiles and Key Figures in Therapeutic Radiopharmaceuticals Business
14.1 Bayer
14.1.1 Bayer Company Profile
14.1.2 Bayer Therapeutic Radiopharmaceuticals Product Specification
14.1.3 Bayer Therapeutic Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.2 Novartis
14.2.1 Novartis Company Profile
14.2.2 Novartis Therapeutic Radiopharmaceuticals Product Specification
14.2.3 Novartis Therapeutic Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.3 China Isotope & Radiation
14.3.1 China Isotope & Radiation Company Profile
14.3.2 China Isotope & Radiation Therapeutic Radiopharmaceuticals Product Specification
14.3.3 China Isotope & Radiation Therapeutic Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.4 Dongcheng
14.4.1 Dongcheng Company Profile
14.4.2 Dongcheng Therapeutic Radiopharmaceuticals Product Specification
14.4.3 Dongcheng Therapeutic Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.5 Q BioMed
14.5.1 Q BioMed Company Profile
14.5.2 Q BioMed Therapeutic Radiopharmaceuticals Product Specification
14.5.3 Q BioMed Therapeutic Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.6 Curium Pharmaceuticals
14.6.1 Curium Pharmaceuticals Company Profile
14.6.2 Curium Pharmaceuticals Therapeutic Radiopharmaceuticals Product Specification
14.6.3 Curium Pharmaceuticals Therapeutic Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.7 Jubilant DraxImage
14.7.1 Jubilant DraxImage Company Profile
14.7.2 Jubilant DraxImage Therapeutic Radiopharmaceuticals Product Specification
14.7.3 Jubilant DraxImage Therapeutic Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.8 Lantheus
14.8.1 Lantheus Company Profile
14.8.2 Lantheus Therapeutic Radiopharmaceuticals Product Specification
14.8.3 Lantheus Therapeutic Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.9 Spectrum Pharmaceuticals
14.9.1 Spectrum Pharmaceuticals Company Profile
14.9.2 Spectrum Pharmaceuticals Therapeutic Radiopharmaceuticals Product Specification
14.9.3 Spectrum Pharmaceuticals Therapeutic Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.10 Progenics Pharmaceuticals
14.10.1 Progenics Pharmaceuticals Company Profile
14.10.2 Progenics Pharmaceuticals Therapeutic Radiopharmaceuticals Product Specification
14.10.3 Progenics Pharmaceuticals Therapeutic Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.11 International Isotopes
14.11.1 International Isotopes Company Profile
14.11.2 International Isotopes Therapeutic Radiopharmaceuticals Product Specification
14.11.3 International Isotopes Therapeutic Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Chapter 15 Global Therapeutic Radiopharmaceuticals Market Forecast (2022-2027)
15.1 Global Therapeutic Radiopharmaceuticals Consumption Volume, Revenue and Price Forecast (2022-2027)
15.1.1 Global Therapeutic Radiopharmaceuticals Consumption Volume and Growth Rate Forecast (2022-2027)
15.1.2 Global Therapeutic Radiopharmaceuticals Value and Growth Rate Forecast (2022-2027)
15.2 Global Therapeutic Radiopharmaceuticals Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027)
15.2.1 Global Therapeutic Radiopharmaceuticals Consumption Volume and Growth Rate Forecast by Regions (2022-2027)
15.2.2 Global Therapeutic Radiopharmaceuticals Value and Growth Rate Forecast by Regions (2022-2027)
15.2.3 North America Therapeutic Radiopharmaceuticals Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.4 East Asia Therapeutic Radiopharmaceuticals Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.5 Europe Therapeutic Radiopharmaceuticals Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.6 South Asia Therapeutic Radiopharmaceuticals Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.7 Southeast Asia Therapeutic Radiopharmaceuticals Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.8 Middle East Therapeutic Radiopharmaceuticals Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.9 Africa Therapeutic Radiopharmaceuticals Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.10 Oceania Therapeutic Radiopharmaceuticals Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.11 South America Therapeutic Radiopharmaceuticals Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.3 Global Therapeutic Radiopharmaceuticals Consumption Volume, Revenue and Price Forecast by Type (2022-2027)
15.3.1 Global Therapeutic Radiopharmaceuticals Consumption Forecast by Type (2022-2027)
15.3.2 Global Therapeutic Radiopharmaceuticals Revenue Forecast by Type (2022-2027)
15.3.3 Global Therapeutic Radiopharmaceuticals Price Forecast by Type (2022-2027)
15.4 Global Therapeutic Radiopharmaceuticals Consumption Volume Forecast by Application (2022-2027)
15.5 Therapeutic Radiopharmaceuticals Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
